Search
for
Sort by
Research 481–510 of 780
- Treatment of Refractory Segmental Vitiligo and Alopecia Areata in a Child with Upadacitinib and NB-UVB: A Case Report
- Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases
- Primary cicatricial alopecias are characterized by dysregulation of shared gene expression pathways
- Predominant expression of interleukin (IL)‐17 in chronic alopecia areata compared to IFN‐γ in pathogenic Th17 cells, tissue‐resident memory T cells and natural killer cells
- Ex Vivo Treatment with Allogenic Mesenchymal Stem Cells of a Healthy Donor on Peripheral Blood Mononuclear Cells of Patients with Severe Alopecia Areata: Targeting Dysregulated T Cells and the Acquisition of Immunotolerance
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion
- Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells
- The prostaglandin synthases, COX-2 and L-PGDS, mediate prostate hyperplasia induced by low-dose bisphenol A
- Research Progress in Chronic Autoimmune Urticaria
- Hemp Seed-Derived Exosomes Protect Against Dihydrotestosterone-Induced Chicken Feather Growth Inhibition
- Myeloproliferative disorder associated with alopecia universalis
- Hair Growth Effect of DN106212 in C57BL/6 Mouse and Its Network Pharmacological Mechanism of Action
- New therapies for alopecia areata
- Ritlecitinib in severe alopecia areata: a profile of its use
- Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism
- Tofacitinib for the treatment of alopecia areata and variants in adolescents
- Sublingual tofacitinib for alopecia areata: a roll‐over pilot clinical trial and analysis of pharmacokinetics
- Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies
- Case Series and Literature Review on Tofacitinib for Treating Severe Alopecia Areata
- Good efficacy achieved by telitacicept in treatment of systemic lupus erythematosus with alopecia areata
- Effects of the RV3466F lotion on female telogen effluvium: Results from a 16 week, multi-centric, controlled, randomized trial
- Real-World Evidence for Baricitinib in the Treatment of Atopic Dermatitis and Alopecia Areata: Systematic Literature Review 2020–2023
- Effect of tofacitinib on the expression of noggin/BMP-4 and hair growth stimulation in mice
- Upadacitinib Therapy in Adolescent Severe Alopecia Areata: A Case Series and Narrative Review
- Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata
- Retrospective Analysis of Oral Tofacitinib Treatment for Alopecia Areata at a Tertiary Care Hospital in Saudi Arabia
- A consensus-based treatment algorithm for alopecia areata in adolescents and adults: integrating severity, quality of life, and disease dynamics
- Hidradenitis suppurativa: a new therapeutic approach for an old disease
- Efficacy of tofacitinib in treatment of alopecia universalis in two patients